Reportable Segments (Tables)

12 Months Ended

Jul. 31, 2020

Segment Reporting [Abstract]

Information as to operating segments

Information as to reportable segments is summarized below:

	Year Ended July 31,
	2020		2019		2018
Net sales:
Medical	$	468,078	$	523,669	$	473,937
Life Sciences (1)	195,410		194,950		211,210
Dental (1)	322,398		167,680		155,180
Dialysis	30,162		31,856		31,595
Total	$	1,016,048	$	918,155	$	871,922

_______________________________________________

(1)In fiscal 2019 and fiscal 2018, approximately $6,072 and $5,820, respectively, of net sales were reclassified out of our Life Sciences segment and into our Dental segment associated with the changes in our segments noted above.

	Year Ended July 31,
	2020		2019		2018
Income from operations:
Medical	$	56,065	$	98,356	$	86,833
Life Sciences (1)	26,904		17,528		35,100
Dental (1)	3,378		25,313		31,707
Dialysis	7,480		4,922		7,380
	93,827		146,119		161,020
General corporate expenses	45,520		62,600		39,356
Income from operations	48,307		83,519		121,664
Interest expense, net	41,355		9,505		5,289
Other income	—		(1,305)		(1,138)
Income before income taxes	$	6,952	$	75,319	$	117,513

_______________________________________________

(1)In fiscal 2019 and 2018, approximately $3,024 and $1,703 of income from operations were reclassified out of our Life Sciences segment and into our Dental segment associated with the changes in our segments noted above.

	July 31,
	2020		2019
Identifiable assets:
Medical	$	549,194	$	532,250
Life Sciences	157,115		184,737
Dental	1,037,947		272,309
Dialysis	19,114		19,016
General corporate, including cash and cash equivalents	308,384		62,054
Total	$	2,071,754	$	1,070,366

	Year Ended July 31,
	2020		2019		2018
Capital expenditures:
Medical	$	15,587	$	52,907	$	18,996
Life Sciences	2,134		16,408		4,409
Dental	15,304		16,243		2,441
Dialysis	771		3,203		644
General corporate	—		6,677		11,208
Total	$	33,796	95,438		37,698

	Year Ended July 31,
	2020		2019		2018
Depreciation and amortization:
Medical	$	24,133	$	23,033	$	19,002
Life Sciences	6,856		7,482		5,628
Dental	29,702		9,844		8,756
Dialysis	44		39		711
General corporate	2,667		1,961		733
Total	$	63,402	$	42,359	$	34,830

Information as to geographic areas

Information as to geographic areas (including net sales which represent the geographic area from which we derive its net sales from external customers) is summarized below:

	Year Ended July 31,
	2020		2019		2018
Net sales:
United States	$	742,410	$	665,661	$	643,744
Europe/Africa/Middle East	167,360		148,334		131,130
Asia/Pacific	73,517		66,228		57,108
Canada	27,417		32,152		33,524
Latin America/South America	5,344		5,780		6,416
Total	$	1,016,048	$	918,155	$	871,922

	July 31,
	2020		2019
Total long-lived assets:
United States	$	211,701	$	128,010
Europe/Africa/Middle East	60,752		64,742
Asia/Pacific	7,478		4,201
Canada	4,993		1,995
Total	284,924		198,948
Goodwill and intangible assets, net	1,140,204		519,622
Total	$	1,425,128	$	718,570